Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Haemonetics Corp (HAE)
Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,304,951
  • Shares Outstanding, K 50,742
  • Annual Sales, $ 1,169 M
  • Annual Income, $ 115,400 K
  • 60-Month Beta 0.34
  • Price/Sales 3.62
  • Price/Cash Flow 16.51
  • Price/Book 4.66
Trade HAE with:

Options Overview Details

View History
  • Implied Volatility 31.09% ( +1.24%)
  • Historical Volatility 30.60%
  • IV Percentile 27%
  • IV Rank 31.39%
  • IV High 51.96% on 10/27/23
  • IV Low 21.55% on 05/16/23
  • Put/Call Vol Ratio 1.50
  • Today's Volume 5
  • Volume Avg (30-Day) 74
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 3,903
  • Open Int (30-Day) 4,135

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.97
  • Number of Estimates 3
  • High Estimate 1.00
  • Low Estimate 0.95
  • Prior Year 0.85
  • Growth Rate Est. (year over year) +14.12%

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.97 +6.09%
on 11/29/23
90.53 -6.29%
on 11/15/23
-1.33 (-1.54%)
since 11/08/23
3-Month
79.97 +6.09%
on 11/29/23
93.58 -9.34%
on 10/10/23
-3.64 (-4.11%)
since 09/08/23
52-Week
72.26 +17.41%
on 01/09/23
95.26 -10.94%
on 08/08/23
+1.12 (+1.34%)
since 12/08/22

Most Recent Stories

More News
Stocks in play: OpSens Inc.

Announces that the Superior Court of Québec issued a final order today in connection with the previously ...

HAE : 84.84 (+1.90%)
OPS.TO : 2.89 (unch)
OPSENS RECEIVES FINAL ORDER FOR ARRANGEMENT WITH HAEMONETICS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1261 (+0.08%)
HAE : 84.84 (+1.90%)
OPS.TO : 2.89 (unch)
OPSENS' SHAREHOLDERS APPROVE ARRANGEMENT WITH HAEMONETICS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1261 (+0.08%)
HAE : 84.84 (+1.90%)
OPS.TO : 2.89 (unch)
OPSENS OBTAINS REGULATORY CLEARANCE OF ARRANGEMENT IN THE UNITED STATES AND CANADA; REGULATORY APPROVALS CONDITION SATISFIED

All amounts in this press release are in Canadian dollars. Clearance under both the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the...

OPSSF : 2.1261 (+0.08%)
HAE : 84.84 (+1.90%)
OPS.TO : 2.89 (unch)
3 Medical Stocks to Buy for Future Investments

The medical industry is expected to grow due to robust demand and technological advancement. Therefore, investors could consider buying fundamentally strong medical stocks, Medtronic (MDT), Haemonetics...

HAE : 84.84 (+1.90%)
HSTM : 26.00 (+0.46%)
MDT : 79.35 (-0.25%)
INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS SHAREHOLDERS VOTE "FOR" OPSENS INC. PLAN OF ARRANGEMENT WITH HAEMONETICS CORPORATION

All amounts in this press release are in Canadian dollars. Leading independent proxy advisor says cash offer provides meaningful 50.3% premium to OpSens Inc.'s...

OPSSF : 2.1261 (+0.08%)
HAE : 84.84 (+1.90%)
OPS.TO : 2.89 (unch)
OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF) announces that the Québec Superior Court (the "Court") issued an interim order...

OPSSF : 2.1261 (+0.08%)
HAE : 84.84 (+1.90%)
OPS.TO : 2.89 (unch)
Haemonetics: Fiscal Q2 Earnings Snapshot

Haemonetics: Fiscal Q2 Earnings Snapshot

HAE : 84.84 (+1.90%)
OPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY HAEMONETICS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

HAE : 84.84 (+1.90%)
OPSSF : 2.1261 (+0.08%)
OPS.TO : 2.89 (unch)
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023

/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2024 financial results at 6:00 am...

HAE : 84.84 (+1.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood...

See More

Key Turning Points

3rd Resistance Point 87.64
2nd Resistance Point 86.27
1st Resistance Point 85.55
Last Price 84.84
1st Support Level 83.46
2nd Support Level 82.09
3rd Support Level 81.37

See More

52-Week High 95.26
Fibonacci 61.8% 86.47
Last Price 84.84
Fibonacci 50% 83.76
Fibonacci 38.2% 81.05
52-Week Low 72.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar